Dark
Light
Today: May 22, 2024
May 22, 2024
1 min read

SanchiConnect and YourNest VC Accelerator Program for Deeptech Start-ups


TLDR:

  • SanchiConnect and YourNest Venture Capital launched an accelerator program for deeptech start-ups.
  • The program will provide selected start-ups with essential resources, mentorship, and funding.

SanchiConnect and YourNest Venture Capital have joined hands to introduce an accelerator program aimed at supporting deeptech hardware and software start-ups with core intellectual property (IP). The program will offer selected start-ups upfront funding of USD 500k, followed by a 60-day program focusing on go-to-market strategies and international collaborations. YourNest’s Executive Director and Fund Manager, Girish Shivani, highlighted the importance of nurturing deeptech start-ups and fostering technology-led innovation through faster funding initiatives like this one. The program will focus on various technologies such as Artificial Intelligence, Robotics, Quantum Compute, and Wearables, among others.

The accelerator program, in collaboration with SanchiConnect, aims to empower deeptech start-ups and drive innovation in emerging technologies. The selected start-ups will receive resources, mentorship, and funding to accelerate their growth trajectory and make a significant impact in industries like AgriTech, Health Tech, Media/Entertainment, and more. The program is set to invest INR 30 crore under the Velocity Fast Track Startup Funding Program, supporting start-ups in sectors such as Energy, Green Energy, and Telecommunications. This initiative marks a crucial step in catalyzing India’s deeptech start-up ecosystem and fostering technology-led innovation.


Previous Story

Breaking News: Egyptian VC Glint Raises $3m for 2nd Fund

Latest from Blog

LabGenius Secures £35 Million in Series B Round

TLDR: LabGenius, a London-based drug discovery company, raised £35M in Series B funding led by M Ventures. The company plans to use the funds to further develop its machine learning-driven drug discovery
Go toTop